Rutgers, The State University has been awarded a task order against an existing National Institute on Drug Abuse (NIDA) indefinite delivery contract to establish and operate the NIDA Center for Genetic Studies. The task order, valued at $2,716,366, provides continued genetic research services for the Center between March 2023 and March 2024. Specifically, Rutgers will receive, process, store and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants...
The National Institute on Drug Abuse (NIDA) Center for Genetic Studies awarded a $2.5 million firm fixed price delivery order contract to Rutgers, The State University Research Financial Services Division for the period of March 14, 2022 through March 13, 2023. As the prime contractor, Rutgers, The State University Research Financial Services Division will provide research services in support of NIDA's Center for Genetic Studies, with performance taking place in New Brunswick, New Jersey.
This is a $1,647,593 firm-fixed-price delivery order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Rutgers, The State University of New Jersey. The award is for the NIDA Center for Genetic Studies, where Rutgers will receive, process, store, and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts over a 5-year period from March 2023 to March 2028. This delivery order provides $1.6 million...
Rutgers, The State University of New Jersey was awarded a $2.5 million firm fixed-price delivery order against the National Institutes of Health National Institute on Drug Abuse's Center for Genetic Studies indefinite delivery/indefinite quantity contract. Under the one-year task order, Rutgers will provide research services in support of NIDA's mission to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health....
This is a firm fixed-price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Rutgers, The State University. The $2,499,626.17 contract is for the NIDA Center for Genetic Studies, providing services such as receiving, processing, storing, and distributing de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts over a 5-year period from March 2023...
Rutgers, The State University has been awarded a firm fixed price delivery order against the National Institute on Drug Abuse Indefinite Delivery Contract to provide genetic research services. The $26,238.10 contract from the Department of the Navy Bureau of Medicine and Surgery will support Rutgers' continued operation of the NIDA Center for Genetic Studies through December 2023. As the prime contractor, Rutgers will receive, process, store, and distribute de-identified clinical data and...
This is a delivery order under a $15 million Indefinite Delivery Contract (IDC) awarded by the National Institute on Drug Abuse (NIDA) to Rutgers, The State University. The task order, valued at $2,807,643, is for the NIDA Center for Genetic Studies, which Rutgers operates to receive, process, store, and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts. This supports NIDA's research objectives on genetic factors related to substance...
This contract award is for the NIDA Center for Genetic Studies, which is a single-award Indefinite Delivery Contract from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services National Institutes of Health. The prime contractor is Rutgers, The State University, through its Research Financial Services Division. The contract is for the establishment and operation of the NIDA Center for Genetic Studies, which involves receiving, processing, storing and...
This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, to Rutgers, The State University of New Jersey. The contract is for the NIDA Center for Genetic Studies, with a period of performance from March 14, 2020 to March 13, 2021 and a ceiling value of $2,499,999.99. The contract was awarded as a Firm Fixed Price task order under a larger Indefinite Delivery Contract (IDC) that Rutgers holds with NIDA, which has...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a firm-fixed-price purchase order contract to Rutgers, The State University in the amount of $16,820.23. The contract, which has a completion date of June 30, 2025, is for the provision of custom mouse model CRISPR gene editing services. Rutgers, a major public research institution and 1862 land grant university, will leverage its expertise...
This contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Rutgers, The State University to establish and operate the NIDA Center for Genetic Studies. The contract is a single-award Indefinite Delivery Contract valued at $2,144,869.96 to support the continued genetic research services for the Center between September 2019 and September 2022, with a potential extension through March 2028. The contract is not designated as a set-aside. As the prime contractor, Rutgers will receive, process, store, and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts. Rutgers has provided various research and development services to federal agencies in the past, including work related to addiction genetics, quantum computing, transportation safety, and advanced wireless communications.